KORU Medical Systems, Inc. / Fundamentals
Income statement
- Net revenue
€31.62M - Cost of goods sold
€11.65M - Gross profit
€19.97M - SG&A expenses
€19.13M - R&D expenses
€4.25M - EBITDA
-€3.23M - D&A
€743.10K - EBIT
-€3.98M - Interest expenses
€0.00 - EBT
-€3.86M - Tax expenses
€17.37K - Net income
-€3.87M
Cash flow statement
- Net deferred tax
€0.00 - Non-cash items
-€178.04K - Changes in working capital
€632.91K - Operating cash flow
-€585.28K - Capex
€1.28M - Other investing cash flow
-€12.70K - Net investing cash flow
-€1.31M - Total cash dividends paid
€0.00 - Issuance of common stock
-€106.22K - Debt repayment
-€134.94K - Other financing cash flow
€14.86K - Net financing cash flow
-€166.48K - Foreign exchange effects
€0.00 - Net change in cash
-€2.06M - Cash at end of period
€6.91M - Free cash flow
€691.51K
Balance sheet
- Cash and cash equivalents
€6.91M - Cash and short-term investments
€6.91M - Total receivables
€4.37M - Inventory
€3.39M - Other current assets
€417.44K - Total current assets
€15.08M - Property, plant & equipment
€6.13M - Goodwill
€0.00 - Intangible assets
€599.72K - Long-term investments
€0.00 - Other non-current assets
€84.92K - Total non-current assets
€6.81M - Total assets
€21.89M - Accounts payable
€939.12K - Short-term debt
€452.74K - Other current liabilities
€3.80M - Total current liabilities
€5.19M - Long-term debt
€5.04M - Deferred tax liabilities
€0.00 - Other non-current liabilities
€0.00 - Total non-current liabilities
€2.52M - Total liabilities
€7.71M - Common stock
€426.04K - Retained earnings
-€26.39M - Other equity
€0.00 - Total equity
€14.18M - Total liabilities and shareholders' equity
€21.89M
Company information
- Market capitalization
€142.86M - Employees
80 - Enterprise Value
€142.51M
Company ratios
- Gross margin
-
63.2% Better than peer group: 49.0% - EBITDA margin
-
-10.2% Worse than peer group: -3.7% - EBIT margin
-
-12.6% Even with peer group: -8.7% - EBT margin
-
-12.2% Much better than peer group: -142.3% - Net margin
-
-12.3% Even with peer group: -10.8% - ROE
-
-27.3% Much worse than peer group: 69.0% - ROA
-
-17.7% Worse than peer group: -8.6% - Asset turnover
-
144.4% Much better than peer group: 98.4% - FCF margin
-
-5.9% Even with peer group: -7.4% - FCF yield
-1.3% - Efficiency ratio
110.2% - Net sales per employee
-
€395.20K - Net income per employee
-
-€48.42K